Skip to main navigation Skip to search Skip to main content

Adaptor proteins as targets for cancer prevention

Research output: Contribution to journalShort surveypeer-review

Abstract

This perspective on the report by McCampbell et al. in this issue of the journal (beginning on page 290) addresses the role of insulin receptor substrate (IRS) proteins in cancer progression. The IRS proteins link many cell-surface receptors to signal transduction pathways. Activation of the phosphoinositide-3 kinase/Akt/mammalian target of rapamycin axis normally results in serine phosphorylation and subsequent downregulation of these adaptor proteins. The authors show that changes in the negative feedback regulation of IRS proteins is associated with the progression of endometrial epithelial cells to hyperplasia and cancer. Therefore, understanding the function of adaptor proteins could provide additional strategies for cancer prevention and treatment.

Original languageEnglish (US)
Pages (from-to)263-265
Number of pages3
JournalCancer Prevention Research
Volume3
Issue number3
DOIs
StatePublished - Mar 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Adaptor proteins as targets for cancer prevention'. Together they form a unique fingerprint.

Cite this